Perlara utilizes model organisms (S. cerevisiae, C. elegans and D. melanogaster) in phenotypic screens to identify therapeutic candidates for rare genetic diseases. We have no openings at this time.
Startup Life from our Blog
Hello readers! Last month, we resurrected the old Perlara tradition of recapping the previous month through tweets. It's a monthly roundup of what happened at Perlara - new partnerships, staff news, events that Perlara team members attended, and anything else that was...read more
In our previous CFTR-pancreatitis blog post, I discussed our plan of action for developing yeast models of pancreatitis-associated CFTR variants as a part of our Pancreatitis PerlQuest partnership with Mission: Cure. In this post, I will share with you the progress...read more
Perlara and Mission: Cure - a nonprofit organization with a mission to find a cure for those affected by pancreatitis - recently launched a Pancreatitis PerlQuest partnership. Ethan covers the backstory of this partnership - from the initial intro to developing a...read more